Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?


OverviewForecastChartTranscripts

Takeda Pharmaceutical Ownership Summary


Takeda Pharmaceutical is owned by 0.26% institutional investors, 0.01% insiders, and 99.74% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.83% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTakeda Pharmaceutical0.26%0.01%99.74%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital research global investors13.16M0.83%$174.27M
Morgan stanley4.99M0.32%$64.53M
Goldman sachs group4.63M0.29%$61.28M
Arrowstreet capital, limited partnership4.22M0.27%$55.82M
Brandes investment partners, lp3.50M0.22%$52.11M
Fmr3.39M0.21%$44.83M
First trust advisors lp3.24M0.20%$42.91M
Renaissance3.08M0.19%$40.77M
Van eck associates2.21M0.14%$29.27M
Blackrock funding, inc. /de2.20M0.14%$29.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Managed asset portfolios1.42M2.78%$18.77M
Clean yield group360.09K1.52%$4.77M
Xy capital162.70K1.04%$2.15M
Summit global investments729.20K0.60%$9.65M
Brandes investment partners, lp3.50M0.53%$52.11M
Legacy wealth asset management140.84K0.51%$1.86M
Gold investment management82.15K0.46%$1.09M
Cowen and company530.60K0.19%$6.87M
Bridgefront capital41.40K0.18%$548.11K
First affirmative financial network20.60K0.16%$272.77K

Top Buyers

HolderShares% AssetsChange
Ubs group1.66M0.00%1.59M
Cowen and company530.60K0.19%530.60K
Toronto dominion bank510.60K0.01%510.60K
Bnp paribas arbitrage, snc500.68K0.00%497.46K
Fmr3.39M0.00%477.37K

Top Sellers

HolderShares% AssetsChange
Mondrian investment partners1.54K0.00%-5.09M
Millennium management246.66K0.00%-1.75M
Soleus capital management---1.18M
Bank of america corp /de/867.06K0.00%-616.95K
Blackrock1.44M0.00%-558.24K

New Positions

HolderShares% AssetsChangeValue
Cowen and company530.60K0.19%530.60K$6.87M
Toronto dominion bank510.60K0.01%510.60K$6.76M
Lmr partners llp230.00K0.03%230.00K$3.05M
Balyasny asset management193.20K0.00%193.20K$2.56M
Raymond james financial109.32K0.00%109.32K$1.45M

Sold Out

HolderChange
Northwest financial advisors-1.00
Transamerica financial advisors-1.00
West branch capital-3.00
Point72 asia (singapore) pte.-3.00
Sugarloaf wealth management-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253-98.99%4,050,360-94.38%-1.24%2-98.64%1-98.94%
Dec 31, 2024182-40.13%33,476,783-56.07%29.19%84-48.47%58-31.76%
Sep 30, 20243015.24%76,190,3605.65%423.28%16033.33%85-16.67%
Jun 30, 2024285-10.94%72,112,827-7.86%418.47%120-25.93%10121.69%
Mar 31, 20243202.56%78,262,422-6.37%417.57%16240.87%83-33.60%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Capital Group American Mutual Comp12.89M0.41%-
American Funds American Mutual A12.89M0.41%-
First Trust Value Line® Dividend ETF2.56M0.08%-
VanEck Pharmaceutical ETF1.19M0.04%42.55K
Mondrian Int Eq Delivered Strategy816.00K0.03%-1.77M
MAP Global Equity Composite716.61K0.02%6.57K
Steward International Enhanced Index I651.53K0.02%315.75K
Capital Group American Mutual Trust U0407.53K0.01%94.57K
MAP Global Balanced Composite391.63K0.01%4.24K
Avantis International Equity ETF327.05K0.01%-

Insider Transactions Trends


DateBuySell
2022 Q4--

TAK Ownership FAQ


Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 0.26%, followed by 0.01% insiders and 99.73% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.16M shares, 0.83%), Morgan stanley (4.99M shares, 0.32%), and Goldman sachs group (4.63M shares, 0.29%). Together, they hold 1.44% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Takeda Pharmaceutical.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.78% of its assets in 1.42M Takeda Pharmaceutical shares, valued at 18.77M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

Capital Group American Mutual Comp is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.41% of its total shares outstanding invested in 12.89M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools